Generic and brand-name fluticasone-salmeterol are equally effective in COPD management
1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease (COPD) patients. 2. Using generic versus brand-name fluticasone-salmeterol was associated with no significant difference in the incidence of COPD exacerbations or pneumonia hospitalizations. Evidence Rating Level: 1 (Excellent) Study Rundown: Chronic obstructive pulmonary disease is
Source: 2minutemedicine.com